TP53 and intrahepatic cholangiocarcinoma: They also found three pathways that are substantially affected in ICC: Ras/phosphatidylinositol-4,5-bisphosphate 3-kinase signaling, p53/cell cycle signaling, and transforming growth factor-β/Smad signaling.